The complexity and globalisation of the pharma supply chain make it difficult to maintain consistent quality and compliance. The challenges they face impact the availability, quality and affordability of pharmaceutical products.
Supply chain disruptions are commonly caused by:
- Ingredient and product quality
- Vendor inefficiencies
- Natural disasters
- Pandemics like COVID-19
- Geopolitical issues
- Inventory management issues
- The need for specific storage conditions
- Cost pressures from price regulation
- Varying global regulations
Technological integration problems, including data silos and cybersecurity threats, hinder efficiency and responsiveness. Environmental and ethical concerns, such as the need for sustainable practices and ethical sourcing of raw materials, add another layer of complexity.
Effective workflows that can mitigate these disruptions are data-driven demand planning and an investment in the right technology. Merging the two to tackle supply chain challenges is emerging IoT startup, Controlant.
Controlant: Informing Pharma Supply Chain Planning
Controlant specialises in providing real-time visibility and digital transformation solutions for the pharmaceutical supply chain. Their platform enables leading pharmaceutical companies to reduce waste, ensure patient safety and enhance efficiency with real-time monitoring, actionable insights and automated workflows.
Controlant’s technology supports quality and compliance with pharmaceutical regulations and has a proven success rate, delivering over 6 billion COVID-19 vaccine doses safely. They focus on optimising supply chain agility and resilience, offering detailed data insights and customised notifications to maintain product quality throughout the logistics process.
Find out more in this article about the capabilities of Controlant’s Saga technology.
